HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 11/19/2012 -- Oclaro, Inc. (NASDAQ:OCLR) shares gained 15.18% and closed at $1.29 in yesterday’s session. The company announced the financial results for its first quarter of fiscal year 2013, which ended September 29, 2012. Revenues were $148.8 million for the first quarter of fiscal 2013, compared with revenues of $104.4 million in the fourth quarter of fiscal 2012. Oclaro, Inc., is a provider of optical communications and laser components, modules and subsystems for a range of markets, including telecommunications (telecom), industrial, scientific, consumer electronics and medical.
How To Trade OCLR Now After The Recent Volatile Moves? Find Out Here
Velti Plc (NASDAQ:VELT) fell -11.90% and closed the trading session at $3.85. The market capitalization of the stock remained 250.24 million. The price to sales ratio of VELT was 1.06 while price to cash ratio was 5.58. Velti Plc (NASDAQ:VELT) has updated the financial results for the Q3 of 2012. The company updated revenue of $62.4 million, advanced +62% as compared to the third quarter of 2011. Adjusted net loss of $1.8 million and adjusted Earnings per share was of $(0.03) versus with an adjusted net loss of $1.1 million and adjusted Earnings per share of $(0.02) for the third quarter of 2011.
What Should Investors Do With VELTI Now? Find Out Here
Dynavax Technologies Corporation(NASDAQ:DVAX) shares plunged 50.32% to $2.30 after the company’s Hepatitis vaccine Heplisav did not secure the backing of a U.S. Food and Drug Administration panel for its safety. However, the committee voted in favor of the drug on the efficacy aspect. The FDA’s Vaccines and Related Biological Products Advisory committee voted 13 to one, supporting the efficacy of the vaccine, terming the data as adequately demonstrating its immunogenicity.
Can DVAX Extend Gain? If Yes, How Far It Can Go? Find Out Here
Magnum Hunter Resources Corp (NYSE:MHR) stock traded with a starting price of $3.43, hit high of $3.49 and closed at $3.44. The market capitalization remained at 580.08 million. On November 16,2012, the stock surged +0.29%. Magnum Hunter Resources Corp (NYSE: MHR) has reported the financial results for the quarter ended September 30, 2012. For the Q3 of 2012, total revenue was $69.8 million, advanced +149% as compared to $28.1 million for the same period of 2011.
Is MHR Showing Any Sign of Buy At The Current Market Price? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)